Holen Sie sich die Stockscreener-App
84.90
0.26%
0.22
Schlusskurs vom Vortag:
$84.68
Offen:
$84.68
24-Stunden-Volumen:
604.51K
Relative Volume:
0.48
Marktkapitalisierung:
$9.46B
Einnahmen:
$13.38B
Nettoeinkommen (Verlust:
$418.00M
KGV:
25.64
EPS:
3.3112
Netto-Cashflow:
$391.00M
1W Leistung:
-0.77%
1M Leistung:
-0.35%
6M Leistung:
+7.69%
1J Leistung:
+32.18%
1-Tages-Spanne:
$83.84
$85.34
1-Wochen-Bereich:
$83.92
$88.13
52-Wochen-Spanne:
$62.15
$92.18
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
84.90 | 9.46B | 13.38B | 418.00M | 391.00M | 3.3112 |
MCK
Mckesson Corp
|
1,011.16 | 117.89B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
340.25 | 64.93B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
256.41 | 59.37B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
1.211 | 1.04B | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-07-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2026-06-11 | Hochstufung | BTIG Research | Neutral → Buy |
| 2026-04-16 | Eingeleitet | BTIG Research | Neutral |
| 2026-04-15 | Eingeleitet | Citigroup | Buy |
| 2026-02-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-08-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2025-07-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Henry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ET - Business Wire
Unpacking Q2 Earnings: Henry Schein (NASDAQ:HSIC) In The Context Of Other Dental Equipment & Technology Stocks - Yahoo Finance
Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term - Zacks Investment Research
What You Need To Know Ahead of Henry Schein's Earnings Release - Barchart.com
What You Need To Know Ahead of Henry Schein's Earnings Release - inkl
Henry Schein Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Henry Schein Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Baird Adjusts Henry Schein Price Target to $107 From $109 - marketscreener.com
Baird Adjusts Henry Schein Price Target to $107 From $109 - Yahoo Finance
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo Finance
Leerink Partners Adjusts Price Target on Henry Schein to $92 From $96 - www.marketscreener.com
Leerink Partners Adjusts Price Target on Henry Schein to $92 From $96 - Yahoo Finance
Henry Schein, Inc. Stock 12‑Month Price Target Cut to $97.27, Implies 16% Upside - TradingView
Henry Schein appoints Emmanuel Caprais as CFO - MedTech Dive
Henry Schein marks 20 years of Practice Pink - DrBicuspid.com
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Why is Henry Schein stock sliding today? - Investing.com
Henry Schein, Inc. Announces CFO Changes, Effective November 4, 2026 - marketscreener.com
Henry Schein names Emmanuel Caprais CFO: what it means for Henry Schein stock - AD HOC NEWS
Henry Schein (HSIC) Announces CFO Transition: Emmanuel Caprais t - GuruFocus
Henry Schein names new CFO - HME News
Henry Schein names Emmanuel Caprais as new CFO - Investing.com
Henry Schein Appoints Emmanuel Caprais as CFO Effective November 2026 - Kalkine Media
Henry Schein names former ITT executive as new CFO - StreetInsider
Henry Schein Announces Chief Financial Officer Leadership Transition - Business Wire
Henry Schein stock fell 1.39 percent as analysts set USD 110 target - AD HOC NEWS
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo Finance
Henry Schein, Inc. (HSIC) Options Chain - Yahoo! Finance Canada
HSIC or MMSI: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Henry Schein Celebrates 20 Years of Practice Pink - Dentistry Today
Should Value Investors Buy Henry Schein (HSIC) Stock? - Zacks Investment Research
Should Value Investors Buy Henry Schein (HSIC) Stock? - Yahoo Finance
Henry Schein Marks 20th Anniversary of Practice Pink Initiative - Orthodontic Products
Henry Schein expands credit line while analysts rate Henry Schein stock Moderate Buy - AD HOC NEWS
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein Cares Celebrates 25 Years of Corporate Citizenship - Dentistry Today
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Henry Schein Cares Marks 25 Years of Helping Health Happen® - Eagle-Tribune
Henry Schein Cares Marks 25 Years of Helping Health Happen® - Business Wire
Henry Schein Cares Marks 25 Years of Helping Health Happen® - Yahoo Finance
Henry Schein Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Henry Schein (HSIC): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Henry Schein stock reflects raised 2026 guidance at USD 86.37 - AD HOC NEWS
Ex-Henry Schein manager gets jail for major embezzlement - DrBicuspid.com
Henry Schein Inc Lobbying Profile, 2011 - OpenSecrets
Henry Schein credit supervisor sentenced to prison for embezzling $1.6M from Melville company - Newsday
Henry Schein Q2FY26 Results: Non-GAAP EPS up 15.5%, guidance raised - scanx.trade
Transcript: Henry Schein Q2 2026 Earnings Conference Call - Benzinga
Is Henry Schein Stock Outperforming the Dow? - finance.yahoo.com
Is Henry Schein Stock Outperforming the Dow? - inkl
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Henry Schein Inc-Aktie (HSIC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| HERRING JOSEPH L | Former Director |
Jun 30 '26 |
Proposed Sale |
84.29 |
28,791 |
2,426,793 |
0 |
| Stanley M. Bergman | Affiliate |
Jun 16 '26 |
Proposed Sale |
81.09 |
16,933 |
1,373,097 |
0 |
| DANIEL WILLIAM K | Director |
May 11 '26 |
Buy |
69.19 |
10,000 |
691,900 |
20,000 |
| Popeck Thomas C | CEO, Henry Schein Products |
Mar 19 '26 |
Sale |
72.79 |
1,355 |
98,630 |
86,182 |
| Popeck Thomas C | Officer |
Mar 19 '26 |
Proposed Sale |
72.79 |
1,355 |
98,630 |
0 |
| KUEHN KURT P | Director |
Mar 10 '26 |
Proposed Sale |
78.96 |
2,844 |
224,565 |
0 |
| KUEHN KURT P | Director |
Mar 10 '26 |
Sale |
78.96 |
2,844 |
224,565 |
15,420 |
| LASKAWY PHILIP A | Director |
Mar 05 '26 |
Proposed Sale |
80.36 |
2,844 |
228,544 |
0 |
| LASKAWY PHILIP A | Director |
Mar 05 '26 |
Sale |
80.36 |
2,844 |
228,544 |
21,961 |
| MLOTEK MARK E | Officer |
Mar 04 '26 |
Proposed Sale |
80.80 |
5,925 |
478,739 |
0 |
1.28%
2.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):